Posted on September 13, 2018
Diabetes is a serious illness which produces a metabolic disorder. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes. An estimated 415 million people had diabetes worldwide.
Type 1 diabetes is a serious, lifelong condition where blood glucose levels are too high because the body cannot make a hormone called insulin. A clinical trial of a new investigational drug has been launched to help prevent and manage Type 1 diabetes, have already dosed the first patient in the world with the treatment. The drug, which was developed by scientists Clinical Research Facility (CRF) at Cardiff and Vale University Health Board (UHB), aims to help the regrowth of insulin, which are lost in patients living with the disease.
Two patients have been dosed with this new drug, 72 hours after the treatment, the two patients showed no side effects. Cardiff’s CRF teams are hoping to try the new drug in more adult volunteers to take part in the clinical trial.
The results of this innovative trial in diabetes treatment could be ground-breaking and are part of a wider program of studies to preserve and regrow the insulin-making cells in Type 1 diabetes.